<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
xmlns:EMSArticle="http://webdoc.advanstar.com/rss/module/EMSArticle"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://pharmtech.findpharma.com/pharmtech/servlet/pharmtech_40945.rss?id=40945">
    <title>Pharmaceutical Technology - IT</title>

    <link>http://pharmtech.findpharma.com/pharmtech/IT/Article/list/40945</link>

    <description>Mobile technology, wireless monitoring systems, RFID. LIMS and electronic notebook systems.
    Automation, QBAS, &amp; process analytical technology. Service-oriented architecture &amp; integration. Risk
    management and CAPA.</description>

    <items>
      <rdf:Seq>
        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-16-2009-GSK-and-Nabi-Form-Nicotine-Vac/ArticleStandard/Article/detail/642581?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Protect-Your-Scientific-Intellectual-Property-Proo/ArticleStandard/Article/detail/641752?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Nov-9-2009-Merck-and-Schering-Plough-Begin/ArticleStandard/Article/detail/640959?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-2-2009-Eli-Lilly-Opens-Biotech-Center-/ArticleStandard/Article/detail/639212?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/DIY-Healthcare-Reform/ArticleStandard/Article/detail/639194?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Stay-Afloat-with-Lessons-Learned/ArticleStandard/Article/detail/639195?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/639200?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Simplifying-data-management/ArticleStandard/Article/detail/637637?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-26-2009-OXiGENE-to-Acquire-VaxGen-Warn/ArticleStandard/Article/detail/637174?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-19-2009-Lonza-Drops-Bid-for-Patheon-Pe/ArticleStandard/Article/detail/635533?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-12-2009-GSK-and-Prosensa-Form-Pact-Car/ArticleStandard/Article/detail/633981?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-5-2009-Merck-and-CSL-Sign-Flu-Vaccine-/ArticleStandard/Article/detail/632124?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/EMEA-to-fully-implement-Product-Information-Manage/ArticleStandard/Article/detail/630111?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/631714?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/PhRMAs-Stake-in-Reform/ArticleStandard/Article/detail/631752?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Looking-Ahead-The-Pharmaceutical-Science-Industry/ArticleStandard/Article/detail/631750?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-28-2009-JampJ-and-Crucell-Enter-Colla/ArticleStandard/Article/detail/630279?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Spotlight/The-rise-of-in-silico-RampD/ArticleStandard/Article/detail/629830?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/Medicating-the-order-to-cash-cycle/ArticleStandard/Article/detail/626905?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-21-2009-AstraZeneca-and-Nektar-Sign-L/ArticleStandard/Article/detail/628576?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-14-2009-Evotec-and-Biogen-Idec-Form-P/ArticleStandard/Article/detail/626906?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-7-2009-Facet-Rejects-Biogen-Idecs-Pro/ArticleStandard/Article/detail/624922?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/WITNESS-software-leads-to-success-for-Sanofi/ArticleStandard/Article/detail/623497?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Aug-31-2009-Roche-Purchases-Lonza-Facility/ArticleStandard/Article/detail/623587?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Quality-by-Enforcement/ArticleStandard/Article/detail/624202?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Robots-The-Next-Phase-in-Pharmaceutical-Automation/ArticleStandard/Article/detail/624196?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/The-GoNo-Go-Mindset/ArticleStandard/Article/detail/624651?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/The-benefits-of-risk-based-analyses-during-system-/ArticleStandard/Article/detail/621294?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Aug-24-2009-Warner-Chilcott-Buys-PampG-Pha/ArticleStandard/Article/detail/621551?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Regulatory-Roundup-FDA-Reorganizes-the-Office-of-t/ArticleStandard/Article/detail/620139?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Forest-Labs-and-AstraZene/ArticleStandard/Article/detail/620144?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Uncovering-the-root-cause-of-contamination-and-lev/ArticleStandard/Article/detail/619225?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Nabi-and-GSK-Form-Pact-Ca/ArticleStandard/Article/detail/618405?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Cherokee-and-DuPont-Form-/ArticleStandard/Article/detail/616603?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/For-Biotherapeutics-Innovation-is-Not-Enough/ArticleStandard/Article/detail/615816?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/615818?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Of-Hubris-and-Happy-Endings/ArticleStandard/Article/detail/615813?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Notes-Amgen-and-GSK-/ArticleStandard/Article/detail/614815?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Formulation/Computer-Model-May-Help-Prevent-Antibody-Aggregati/ArticleStandard/Article/detail/614820?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Briefs-Teva-and-Orth/ArticleStandard/Article/detail/612961?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Merck-and-Portola-Sign-Ag/ArticleStandard/Article/detail/611109?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-and-Graceway-Form-/ArticleStandard/Article/detail/609491?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Can-Industry-Learn-to-Share/ArticleStandard/Article/detail/607463?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Manufacturers-Face-New-Risk-Management-Requirement/ArticleStandard/Article/detail/607455?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-and-Chroma-Form-Devel/ArticleStandard/Article/detail/607999?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/607460?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/The-Good-Society/ArticleStandard/Article/detail/607467?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Pharmas-Facebook/ArticleStandard/Article/detail/605698?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Product-information-management-and-the-pharma-indu/ArticleStandard/Article/detail/606738?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Synta-and-GSK-End-Agreeme/ArticleStandard/Article/detail/606500?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Dr-Reddy-and-GSK-Form-Pac/ArticleStandard/Article/detail/604472?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CSL-and-Talecris-Terminat/ArticleStandard/Article/detail/602720?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/GAO-Recommends-That-FDA-Ensure-Data-Security-withi/ArticleStandard/Article/detail/602699?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-and-Merck-Col/ArticleStandard/Article/detail/601645?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Truth-and-Transparency/ArticleStandard/Article/detail/600808?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Drug-Serialization-and-Supply-Chain-Security/ArticleStandard/Article/detail/601169?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Quality-in-Quality-Out/ArticleStandard/Article/detail/601167?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Beneath-the-Surface/ArticleStandard/Article/detail/600812?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Master-data-management-solutions/ArticleStandard/Article/detail/598921?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-Forms-Licensing-Ag/ArticleStandard/Article/detail/600299?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Teva-and-Lonza-Joint-Vent/ArticleStandard/Article/detail/599148?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Teaching-a-New-Robot-Old-Tricks/ArticleStandard/Article/detail/598567?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/FDA-Issues-First-Sentinel-Initiative-Project-Repor/ArticleStandard/Article/detail/597996?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-Forms-Pact-with-Aspen/ArticleStandard/Article/detail/598063?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Jubilant-Biosys-Forms-Pac/ArticleStandard/Article/detail/597076?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Shop-Floor-and-Top-Floor-Unite/ArticleStandard/Article/detail/596049?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/596046?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Biotechnology-in-2009/ArticleStandard/Article/detail/596053?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Greg-Cruikshank-151-scientists-at-the-forefront-of/ArticleStandard/Article/detail/593903?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Information+Technology/Elevating-laboratory-informatics-to-assist-decisio/ArticleStandard/Article/detail/595063?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CIGNA-and-Merck-Agree-on-/ArticleStandard/Article/detail/595723?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Company-and-People-Notes-GSK-Acquires-Stiefel-Labo/ArticleStandard/Article/detail/594648?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-DSM-and-Shire-Form-Pact-P/ArticleStandard/Article/detail/593691?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Latest+News/Social-networking-for-scientists/ArticleStandard/Article/detail/591058?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-BMS-and-Otsuka-Extend-Abi/ArticleStandard/Article/detail/592425?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/591371?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Parallel-Tracks/ArticleStandard/Article/detail/590455?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Viewpoint/Automation-Vendor-or-Partner/ArticleStandard/Article/detail/590466?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/PharmTech+Talk/Moving-Toward-a-Drug-Development-Boon-or-Bust/ArticleStandard/Article/detail/590456?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-EMD-Serono-to-Open-Cambri/ArticleStandard/Article/detail/590969?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Daiichi-Sankyo-Sues-13-Ge/ArticleStandard/Article/detail/589404?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Gilead-Sciences-to-Acquir/ArticleStandard/Article/detail/587538?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-MannKind-to-Purchase-Pfiz/ArticleStandard/Article/detail/586726?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Elan-Announces-Restructur/ArticleStandard/Article/detail/584824?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/API-Outsourcing-is-Mixed/ArticleStandard/Article/detail/584962?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Critical-Challenges-Require-Core-Values/ArticleStandard/Article/detail/584960?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/584965?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Latest+News/Drug-discovery-the-cheap-way/ArticleStandard/Article/detail/582718?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Genentech-Tells-Sharehold/ArticleStandard/Article/detail/583427?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-KV-Pharmaceutical-Restruc/ArticleStandard/Article/detail/582512?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Releases-Five-Year-Drug-Safety-Plan/ArticleStandard/Article/detail/582342?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Bridging-the-DevelopmentndashManufacturing-Gap-to-/ArticleStandard/Article/detail/581287?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Congress-Introduces-FDA-Globalization-Act-of-2009/ArticleStandard/Article/detail/580861?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-King-Announces-Restructur/ArticleStandard/Article/detail/580965?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-Announces-Mor/ArticleStandard/Article/detail/579768?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Drug-Prices-Remain-on-the-Cutting-Board/ArticleStandard/Article/detail/580028?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Whither-FDA/ArticleStandard/Article/detail/580023?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Pharma-Forecast/ArticleStandard/Article/detail/580024?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Ask-the-Expert-bridging-the-gaps/ArticleStandard/Article/detail/576863?contextCategoryId=40945&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Information+Technology/Efficient-logistic-operations/ArticleStandard/Article/detail/577856?contextCategoryId=40945&amp;ref=25" />
      </rdf:Seq>
    </items>

    <dc:date>2009-11-22T05:09:35Z</dc:date>
  </channel>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-16-2009-GSK-and-Nabi-Form-Nicotine-Vac/ArticleStandard/Article/detail/642581?contextCategoryId=40945&amp;ref=25">

    <title>Week of Nov. 16, 2009: GSK and Nabi Form Nicotine Vaccine Agreement; Eli Lilly Research Exec to Retire;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-16-2009-GSK-and-Nabi-Form-Nicotine-Vac/ArticleStandard/Article/detail/642581?contextCategoryId=40945&amp;ref=25</link>

    <description>Company and People Notes: Genzyme provides updates on enzyme replacement products and FDA complete
    response letter; Watson appoints VP of global operations; more...</description>

    <dc:date>2009-11-19T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/472009/642581null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Protect-Your-Scientific-Intellectual-Property-Proo/ArticleStandard/Article/detail/641752?contextCategoryId=40945&amp;ref=25">

    <title>Protect Your Scientific Intellectual Property: Proof of Lab Informatics Data Authenticity is Your Best Legal
    Defense</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Protect-Your-Scientific-Intellectual-Property-Proo/ArticleStandard/Article/detail/641752?contextCategoryId=40945&amp;ref=25</link>

    <description>As a pharmaceutical or biotechnology organization, your formulas, treatments and clinical findings are
    the &amp;#34;lifeblood&amp;#34; of your business. But if you aren't protecting the integrity of your scientific
    data in your lab informatics systems, you risk losing ownership, revenue and consequently your business if you
    can't prove time-of-creation and authenticity. Learn how you can implement simple, cost-effective, and automated
    controls to protect your scientific intellectual property.</description>

    <dc:date>2009-11-13T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/641752null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Nov-9-2009-Merck-and-Schering-Plough-Begin/ArticleStandard/Article/detail/640959?contextCategoryId=40945&amp;ref=25">

    <title>Week of Nov. 9, 2009: Merck and Schering-Plough Begin Combined Operations; UCB Appoints VP; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Nov-9-2009-Merck-and-Schering-Plough-Begin/ArticleStandard/Article/detail/640959?contextCategoryId=40945&amp;ref=25</link>

    <description>Company and People Notes: 3M forms agreement with VaxInnate; TRIN Pharma appoints CEO;
    More...</description>

    <dc:date>2009-11-12T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640959null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-2-2009-Eli-Lilly-Opens-Biotech-Center-/ArticleStandard/Article/detail/639212?contextCategoryId=40945&amp;ref=25">

    <title>Week of Nov. 2, 2009: Eli Lilly Opens Biotech Center; Johnson &amp;amp;amp; Johnson Announces Restructuring;
    PPD Acquires Chinese CRO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-2-2009-Eli-Lilly-Opens-Biotech-Center-/ArticleStandard/Article/detail/639212?contextCategoryId=40945&amp;ref=25</link>

    <description>Company and People Notes: sanofi aventis forms pact with Micromet; Laureate Pharma adds members to its
    business team.</description>

    <dc:date>2009-11-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639212null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/DIY-Healthcare-Reform/ArticleStandard/Article/detail/639194?contextCategoryId=40945&amp;ref=25">

    <title>DIY Healthcare Reform</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/DIY-Healthcare-Reform/ArticleStandard/Article/detail/639194?contextCategoryId=40945&amp;ref=25</link>

    <description>While Congress debates hundreds of healthcare plan proposals, perhaps we, the public, can get in the
    game too.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639194null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Stay-Afloat-with-Lessons-Learned/ArticleStandard/Article/detail/639195?contextCategoryId=40945&amp;ref=25">

    <title>Stay Afloat with Lessons Learned</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Stay-Afloat-with-Lessons-Learned/ArticleStandard/Article/detail/639195?contextCategoryId=40945&amp;ref=25</link>

    <description>FDA's Edwin Rivera-Martinez on dodging supply-chain challenges.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639195null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/639200?contextCategoryId=40945&amp;ref=25">

    <title>In the Spotlight</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/639200?contextCategoryId=40945&amp;ref=25</link>

    <description>Editors' Picks of Pharmaceutical Science &amp;amp;amp; Technology Innovations</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639200null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Simplifying-data-management/ArticleStandard/Article/detail/637637?contextCategoryId=40945&amp;ref=25">

    <title>Simplifying data management</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Simplifying-data-management/ArticleStandard/Article/detail/637637?contextCategoryId=40945&amp;ref=25</link>

    <description>Paper is no longer a sufficient format for information storage and interchange in the pharmaceutical
    industry; documents are inflexible and costly for production and storage.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637637null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-26-2009-OXiGENE-to-Acquire-VaxGen-Warn/ArticleStandard/Article/detail/637174?contextCategoryId=40945&amp;ref=25">

    <title>Week of Oct. 26, 2009: OXiGENE to Acquire VaxGen; Warner Chilcott Appoints Global R&amp;amp;amp;D President;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-26-2009-OXiGENE-to-Acquire-VaxGen-Warn/ArticleStandard/Article/detail/637174?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Astellas and Medivation sign development pact; WuXi PharmaTech appoints VP of business
    development, more...</description>

    <dc:date>2009-10-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637174null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-19-2009-Lonza-Drops-Bid-for-Patheon-Pe/ArticleStandard/Article/detail/635533?contextCategoryId=40945&amp;ref=25">

    <title>Week of Oct. 19, 2009: Lonza Drops Bid for Patheon; Peregrine Appoints Head of Regulatory Affairs;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-19-2009-Lonza-Drops-Bid-for-Patheon-Pe/ArticleStandard/Article/detail/635533?contextCategoryId=40945&amp;ref=25</link>

    <description>Company and People Notes: SurModics forms agreement with Roche and Genentech; Hospira names Daphne
    Jones senior VP and chief information officer; more...</description>

    <dc:date>2009-10-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635533null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-12-2009-GSK-and-Prosensa-Form-Pact-Car/ArticleStandard/Article/detail/633981?contextCategoryId=40945&amp;ref=25">

    <title>Week of Oct. 12, 2009: GSK and Prosensa Form Pact; Cardiokine Appoints CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-12-2009-GSK-and-Prosensa-Form-Pact-Car/ArticleStandard/Article/detail/633981?contextCategoryId=40945&amp;ref=25</link>

    <description>Company and People Notes: Bayer Schering Pharma forms collaboration with Compugen; Takeda San
    Francisco appoints VP of process science; more...</description>

    <dc:date>2009-10-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/422009/633981null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-5-2009-Merck-and-CSL-Sign-Flu-Vaccine-/ArticleStandard/Article/detail/632124?contextCategoryId=40945&amp;ref=25">

    <title>Week of Oct. 5, 2009: Merck and CSL Sign Flu Vaccine Pact; Cardinal Health Names VP; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-5-2009-Merck-and-CSL-Sign-Flu-Vaccine-/ArticleStandard/Article/detail/632124?contextCategoryId=40945&amp;ref=25</link>

    <description>Company and People Notes: GSK forms joint venture with China-based Jiangsu Walvax Biotech;
    Sigma-Aldrich appoints VP and board member; more...</description>

    <dc:date>2009-10-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632124null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/EMEA-to-fully-implement-Product-Information-Manage/ArticleStandard/Article/detail/630111?contextCategoryId=40945&amp;ref=25">

    <title>EMEA to fully implement Product Information Management</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/EMEA-to-fully-implement-Product-Information-Manage/ArticleStandard/Article/detail/630111?contextCategoryId=40945&amp;ref=25</link>

    <description>The EMEA intends to fully implement its Product Information Management (PIM) approach, an initiative
    designed to improve information management, into the centralized procedure within 2 years, according to a statement
    of intent from the agency.</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630111null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/631714?contextCategoryId=40945&amp;ref=25">

    <title>In the Spotlight</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/631714?contextCategoryId=40945&amp;ref=25</link>

    <description>Editors' Picks of Pharmaceutical Science &amp;amp;amp; Technology Innovations</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631714null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/PhRMAs-Stake-in-Reform/ArticleStandard/Article/detail/631752?contextCategoryId=40945&amp;ref=25">

    <title>PhRMA's Stake in Reform</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/PhRMAs-Stake-in-Reform/ArticleStandard/Article/detail/631752?contextCategoryId=40945&amp;ref=25</link>

    <description>The nation's healtcare system needs an overhaul, but it has to be done right.</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631752null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Looking-Ahead-The-Pharmaceutical-Science-Industry/ArticleStandard/Article/detail/631750?contextCategoryId=40945&amp;ref=25">

    <title>Looking Ahead: The Pharmaceutical-Science Industry</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Looking-Ahead-The-Pharmaceutical-Science-Industry/ArticleStandard/Article/detail/631750?contextCategoryId=40945&amp;ref=25</link>

    <description>AAPS President offers hope and solutions for the industry's challenging future.</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631750null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-28-2009-JampJ-and-Crucell-Enter-Colla/ArticleStandard/Article/detail/630279?contextCategoryId=40945&amp;ref=25">

    <title>Week of Sept. 28, 2009: J&amp;amp;amp;J and Crucell Enter Collaboration; Pfizer Elects Two Directors;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-28-2009-JampJ-and-Crucell-Enter-Colla/ArticleStandard/Article/detail/630279?contextCategoryId=40945&amp;ref=25</link>

    <description>Company and People Notes: Boehringer Ingelheim will acquire Wyeth's animal health business; Amsterdam
    Molecular Therapeutics appoints CEO; more...</description>

    <dc:date>2009-10-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630279null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Spotlight/The-rise-of-in-silico-RampD/ArticleStandard/Article/detail/629830?contextCategoryId=40945&amp;ref=25">

    <title>The rise of in silico R&amp;amp;amp;D</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Spotlight/The-rise-of-in-silico-RampD/ArticleStandard/Article/detail/629830?contextCategoryId=40945&amp;ref=25</link>

    <description>Even though the pharmaceutical industry has come to recognize the importance and associated benefits
    of using computers, evolving computer-based simulation technology has still to make a suitable
    impression.</description>

    <dc:date>2009-10-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/629830null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/Medicating-the-order-to-cash-cycle/ArticleStandard/Article/detail/626905?contextCategoryId=40945&amp;ref=25">

    <title>Medicating the order-to-cash cycle</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/Medicating-the-order-to-cash-cycle/ArticleStandard/Article/detail/626905?contextCategoryId=40945&amp;ref=25</link>

    <description>How manufacturers can accelerate cashflow by cutting out the paper trail.</description>

    <dc:date>2009-10-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382009/626905null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-21-2009-AstraZeneca-and-Nektar-Sign-L/ArticleStandard/Article/detail/628576?contextCategoryId=40945&amp;ref=25">

    <title>Week of Sept. 21, 2009: AstraZeneca and Nektar Sign License Agreement; Eli Lilly Names President of Lilly
    USA, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-21-2009-AstraZeneca-and-Nektar-Sign-L/ArticleStandard/Article/detail/628576?contextCategoryId=40945&amp;ref=25</link>

    <description>Company and People Notes: Wyeth and Ambrx form development pact; Elite Pharma appoints CEO and CSO;
    more...</description>

    <dc:date>2009-09-24T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/628576null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-14-2009-Evotec-and-Biogen-Idec-Form-P/ArticleStandard/Article/detail/626906?contextCategoryId=40945&amp;ref=25">

    <title>Week of Sept. 14, 2009: Evotec and Biogen Idec Form Pact; Marijn Dekkers Leaves Thermo Fisher Scientific for
    Bayer; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-14-2009-Evotec-and-Biogen-Idec-Form-P/ArticleStandard/Article/detail/626906?contextCategoryId=40945&amp;ref=25</link>

    <description>Company and People Notes: Sanofi Pasteur signs H1N1 vaccine deal with Brazilian government; Helsinn
    Group appoints CEO of US business; more...</description>

    <dc:date>2009-09-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382009/626906null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-7-2009-Facet-Rejects-Biogen-Idecs-Pro/ArticleStandard/Article/detail/624922?contextCategoryId=40945&amp;ref=25">

    <title>Week of Sept. 7, 2009: Facet Rejects Biogen Idec's Proposal; Roche Announces Management Changes;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-7-2009-Facet-Rejects-Biogen-Idecs-Pro/ArticleStandard/Article/detail/624922?contextCategoryId=40945&amp;ref=25</link>

    <description>Company and People Notes: Neoprobe and Laureate Pharma form manufacturing agreement; Akela Pharma
    appoints CEO and chairman; more...</description>

    <dc:date>2009-09-10T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624922null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/WITNESS-software-leads-to-success-for-Sanofi/ArticleStandard/Article/detail/623497?contextCategoryId=40945&amp;ref=25">

    <title>WITNESS software leads to success for Sanofi</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/WITNESS-software-leads-to-success-for-Sanofi/ArticleStandard/Article/detail/623497?contextCategoryId=40945&amp;ref=25</link>

    <description>Sanofi aventis has finished implementing Lanner's process simulation software into one of its major UK
    sites following a successful Phase I implementation in which the company made more than &amp;amp;pound;1 million in
    inventory cost savings in 6 months.</description>

    <dc:date>2009-09-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623497null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Aug-31-2009-Roche-Purchases-Lonza-Facility/ArticleStandard/Article/detail/623587?contextCategoryId=40945&amp;ref=25">

    <title>Week of Aug. 31, 2009: Roche Purchases Lonza Facility; SCOLR Pharma Names CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Aug-31-2009-Roche-Purchases-Lonza-Facility/ArticleStandard/Article/detail/623587?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Orexo and Novartis form agreement; Affitech appoints Robert Burns CEO; more...</description>

    <dc:date>2009-09-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623587null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Quality-by-Enforcement/ArticleStandard/Article/detail/624202?contextCategoryId=40945&amp;ref=25">

    <title>Quality by Enforcement</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Quality-by-Enforcement/ArticleStandard/Article/detail/624202?contextCategoryId=40945&amp;ref=25</link>

    <description>After years of promomting QbD concepts, FDA's ready to take action on nonconformers.</description>

    <dc:date>2009-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/624202null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Robots-The-Next-Phase-in-Pharmaceutical-Automation/ArticleStandard/Article/detail/624196?contextCategoryId=40945&amp;ref=25">

    <title>Robots: The Next Phase in Pharmaceutical Automation</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Robots-The-Next-Phase-in-Pharmaceutical-Automation/ArticleStandard/Article/detail/624196?contextCategoryId=40945&amp;ref=25</link>

    <description>Robotic systems provide flexibility and efficiency (and they're not as difficult to use as you think).
    This article contains bonus online-exclusive material.</description>

    <dc:date>2009-09-02T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/624196/ROBOT_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/624196/Bonus_main.gif</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/624196null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/The-GoNo-Go-Mindset/ArticleStandard/Article/detail/624651?contextCategoryId=40945&amp;ref=25">

    <title>The Go/No-Go Mindset</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/The-GoNo-Go-Mindset/ArticleStandard/Article/detail/624651?contextCategoryId=40945&amp;ref=25</link>

    <description>As new process validation guidelines emerge, industry needs to reinvent how it releases
    product.</description>

    <dc:date>2009-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624651null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/The-benefits-of-risk-based-analyses-during-system-/ArticleStandard/Article/detail/621294?contextCategoryId=40945&amp;ref=25">

    <title>The benefits of risk-based analyses during system validation</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/The-benefits-of-risk-based-analyses-during-system-/ArticleStandard/Article/detail/621294?contextCategoryId=40945&amp;ref=25</link>

    <description>When validating automated systems from third-party providers, using the V model and failure modes
    effects and criticality analysis (FMECA) early in the process can help.</description>

    <dc:date>2009-09-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621294/Woods_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621294null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Aug-24-2009-Warner-Chilcott-Buys-PampG-Pha/ArticleStandard/Article/detail/621551?contextCategoryId=40945&amp;ref=25">

    <title>Week of Aug. 24, 2009: Warner Chilcott Buys P&amp;amp;amp;G Pharma Business; Amylin Appoints Former Novartis
    Exec As Chairman; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Aug-24-2009-Warner-Chilcott-Buys-PampG-Pha/ArticleStandard/Article/detail/621551?contextCategoryId=40945&amp;ref=25</link>

    <description>Company and People Notes: UCB and Novartis form agreement; AAIPharma appoints VP of regulatory
    affairs; more...</description>

    <dc:date>2009-08-27T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621551null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Regulatory-Roundup-FDA-Reorganizes-the-Office-of-t/ArticleStandard/Article/detail/620139?contextCategoryId=40945&amp;ref=25">

    <title>Regulatory Roundup: FDA Reorganizes the Office of the Commissioner, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Regulatory-Roundup-FDA-Reorganizes-the-Office-of-t/ArticleStandard/Article/detail/620139?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, FDA publishes draft guidances of two ICH Annexes; EMEA sets format for compliance advice;
    more...</description>

    <dc:date>2009-08-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620139null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Forest-Labs-and-AstraZene/ArticleStandard/Article/detail/620144?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: Forest Labs and AstraZeneca Form Pact; Endo COO Resigns; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Forest-Labs-and-AstraZene/ArticleStandard/Article/detail/620144?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, XCELERON and GSK form agreement; Millipore appoints VP of life sciences; more...</description>

    <dc:date>2009-08-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620144null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Uncovering-the-root-cause-of-contamination-and-lev/ArticleStandard/Article/detail/619225?contextCategoryId=40945&amp;ref=25">

    <title>Uncovering the root cause of contamination and leveraging the collaborative learning loop of QbD</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Uncovering-the-root-cause-of-contamination-and-lev/ArticleStandard/Article/detail/619225?contextCategoryId=40945&amp;ref=25</link>

    <description>This article will share a detailed case study problem-solving example about a pharmaceutical
    manufacturer investigating a contaminant for a specific drug outcome. Step-by-step tutorial descriptions and
    graphics will illustrate how multivariate analysis can be used to determine the root cause of contaminated batches
    and ultimately solve the problem by accounting for batch genealogy. Examples are shared about how to use enabling
    technology, including: 1) Setting and reviewing specific parameters, such as the average pH and temperature of the
    fermentor. 2) Conducting comparisons of average flow rate, pressure and viscosity across contaminated batches. 3)
    Examining scatter plots to find correlations through regression analysis.</description>

    <dc:date>2009-08-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/619225null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Nabi-and-GSK-Form-Pact-Ca/ArticleStandard/Article/detail/618405?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: Nabi and GSK Form Pact; Cardinal Health Names CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Nabi-and-GSK-Form-Pact-Ca/ArticleStandard/Article/detail/618405?contextCategoryId=40945&amp;ref=25</link>

    <description>Also: DSM's North Carolina facility receives SafeBridge certification; Dynavax CFO to retire;
    more...</description>

    <dc:date>2009-08-13T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/618405null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Cherokee-and-DuPont-Form-/ArticleStandard/Article/detail/616603?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: Cherokee and DuPont Form Supply Agreement; Mylan Makes Changes in Management Team;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Cherokee-and-DuPont-Form-/ArticleStandard/Article/detail/616603?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Pfizer forms two research agreements in China; NanoInk appoints John Kubricky to its scientific
    advisory board; more...</description>

    <dc:date>2009-08-06T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322009/616603null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/For-Biotherapeutics-Innovation-is-Not-Enough/ArticleStandard/Article/detail/615816?contextCategoryId=40945&amp;ref=25">

    <title>For Biotherapeutics, Innovation is Not Enough</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/For-Biotherapeutics-Innovation-is-Not-Enough/ArticleStandard/Article/detail/615816?contextCategoryId=40945&amp;ref=25</link>

    <description>Biotech firms must first close the gaps between science and biology on the path toward
    QbD.</description>

    <dc:date>2009-08-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615816null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/615818?contextCategoryId=40945&amp;ref=25">

    <title>In the Spotlight</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/615818?contextCategoryId=40945&amp;ref=25</link>

    <description>Editors' Picks of Pharmaceutical Science &amp;amp;amp; Technology Innovations</description>

    <dc:date>2009-08-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615818null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Of-Hubris-and-Happy-Endings/ArticleStandard/Article/detail/615813?contextCategoryId=40945&amp;ref=25">

    <title>Of Hubris and Happy Endings</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Of-Hubris-and-Happy-Endings/ArticleStandard/Article/detail/615813?contextCategoryId=40945&amp;ref=25</link>

    <description>Individuals and companies at the top seem to have no problem short-circuiting their
    success.</description>

    <dc:date>2009-08-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615813null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Notes-Amgen-and-GSK-/ArticleStandard/Article/detail/614815?contextCategoryId=40945&amp;ref=25">

    <title>Company, People, and Regulatory Notes: Amgen and GSK Collaborate; WuXi Appoints VP of Pharmacology;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Notes-Amgen-and-GSK-/ArticleStandard/Article/detail/614815?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Isogen completes sterile facility; Dishman appoints head of generic API business; FDA releases
    final rule on authorized generic drugs and NDA submissions; more...</description>

    <dc:date>2009-07-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/614815null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Formulation/Computer-Model-May-Help-Prevent-Antibody-Aggregati/ArticleStandard/Article/detail/614820?contextCategoryId=40945&amp;ref=25">

    <title>Computer Model May Help Prevent Antibody Aggregation</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Formulation/Computer-Model-May-Help-Prevent-Antibody-Aggregati/ArticleStandard/Article/detail/614820?contextCategoryId=40945&amp;ref=25</link>

    <description>Researchers working on extending the shelf life of antibody drugs may find help in a computer model
    developed by a research team at MIT (Cambridge, MA).</description>

    <dc:date>2009-07-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/614820null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Briefs-Teva-and-Orth/ArticleStandard/Article/detail/612961?contextCategoryId=40945&amp;ref=25">

    <title>Company, People, and Regulatory Briefs: Teva and Ortho Extend Agreement; Biogen Idec Cofounder Retires;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Briefs-Teva-and-Orth/ArticleStandard/Article/detail/612961?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Gilead and Tibotec form agreement; FDA approves 2009-2010 flu vaccine; Catalent appoints VP in
    packaging unit; more...</description>

    <dc:date>2009-07-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/302009/612961null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Merck-and-Portola-Sign-Ag/ArticleStandard/Article/detail/611109?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: Merck and Portola Sign Agreement; Eisai Appoints Senior Vice-Presidents; More
    ...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Merck-and-Portola-Sign-Ag/ArticleStandard/Article/detail/611109?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Lonza and Medarex sign agreement; Covance appoints VP and chief scientific officer of global
    analytical services; more...</description>

    <dc:date>2009-07-16T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292009/611109null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-and-Graceway-Form-/ArticleStandard/Article/detail/609491?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: Pfizer and Graceway Form Deal; GeoVax Labs Leader Resigns; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-and-Graceway-Form-/ArticleStandard/Article/detail/609491?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Lundbeck acquired LifeHealth; FDA is seeking a director of its new tobacco regulation branch;
    Charles River Labs announces personnel changes; more...</description>

    <dc:date>2009-07-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282009/609491null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Can-Industry-Learn-to-Share/ArticleStandard/Article/detail/607463?contextCategoryId=40945&amp;ref=25">

    <title>Can Industry Learn to Share?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Can-Industry-Learn-to-Share/ArticleStandard/Article/detail/607463?contextCategoryId=40945&amp;ref=25</link>

    <description>The regulators are doing it. But industry's fear of sharing information may leave them
    behind.</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607463null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Manufacturers-Face-New-Risk-Management-Requirement/ArticleStandard/Article/detail/607455?contextCategoryId=40945&amp;ref=25">

    <title>Manufacturers Face New Risk-Management Requirements</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Manufacturers-Face-New-Risk-Management-Requirement/ArticleStandard/Article/detail/607455?contextCategoryId=40945&amp;ref=25</link>

    <description>REMS to improve the safe use of opioids may lead to controls on other high-risk
    medicines.</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607455null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-and-Chroma-Form-Devel/ArticleStandard/Article/detail/607999?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: GSK and Chroma Form Development Pact; Siemen's Healthcare Appoints US CEO;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-and-Chroma-Form-Devel/ArticleStandard/Article/detail/607999?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Wyeth and Catalyst sign agreement; FDA seeks public opinion about tobacco regulation; Catalent
    appoints VP of quality and regulatory affairs; more...</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607999null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/607460?contextCategoryId=40945&amp;ref=25">

    <title>In the Spotlight</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/607460?contextCategoryId=40945&amp;ref=25</link>

    <description>Editors' Picks of Pharmaceutical Science &amp;amp;amp; Technology Innovations</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607460null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/The-Good-Society/ArticleStandard/Article/detail/607467?contextCategoryId=40945&amp;ref=25">

    <title>The Good Society</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/The-Good-Society/ArticleStandard/Article/detail/607467?contextCategoryId=40945&amp;ref=25</link>

    <description>Is it good policy to pay for bad behavior?</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607467null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Pharmas-Facebook/ArticleStandard/Article/detail/605698?contextCategoryId=40945&amp;ref=25">

    <title>Pharma's Facebook</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Pharmas-Facebook/ArticleStandard/Article/detail/605698?contextCategoryId=40945&amp;ref=25</link>

    <description>Social media is big news. From Facebook to Twitter, individuals are embracing the opportunity to
    participate in online publishing at an unprecedented rate. Communities of users interact globally, minutetominute
    within huge databases of content that they themselves create.</description>

    <dc:date>2009-07-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/262009/605698/LinkedIn_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Product-information-management-and-the-pharma-indu/ArticleStandard/Article/detail/606738?contextCategoryId=40945&amp;ref=25">

    <title>Product information management and the pharma industry</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Product-information-management-and-the-pharma-indu/ArticleStandard/Article/detail/606738?contextCategoryId=40945&amp;ref=25</link>

    <description>Good information management is essential to help pharmaceutical companies efficiently translate large
    amounts of data into drug market applications, achieve fast time to market and reduce costs and in Europe, many
    companies and regulatory agencies are actively assessing the potential of the EMEA's XML-based Product Information
    Management initiative.</description>

    <dc:date>2009-06-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/262009/606738null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Synta-and-GSK-End-Agreeme/ArticleStandard/Article/detail/606500?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: Synta and GSK End Agreement; WuXi Appoints US VP; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Synta-and-GSK-End-Agreeme/ArticleStandard/Article/detail/606500?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Adimab forms deals with Merck and Roche; Manhattan Pharmaceuticals' CEO and president steps
    down; more...</description>

    <dc:date>2009-06-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/606500null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Dr-Reddy-and-GSK-Form-Pac/ArticleStandard/Article/detail/604472?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: Dr. Reddy and GSK Form Pact; Hollis-Eden Appoints CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Dr-Reddy-and-GSK-Form-Pac/ArticleStandard/Article/detail/604472?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, FDA debars clinical investigators; Jubilant Organosys forms deal with Endo Pharmaceuticals; AMRI
    makes changes to its India management team; more...</description>

    <dc:date>2009-06-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252009/604472null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CSL-and-Talecris-Terminat/ArticleStandard/Article/detail/602720?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: CSL and Talecris Terminate Merger Agreement; Eli Lilly Hires Former Indianapolis
    Mayor; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CSL-and-Talecris-Terminat/ArticleStandard/Article/detail/602720?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, TorreyPines Therapeutics to liquidate assets and dissolve company; EU's competition services to
    examine Pfizer/Wyeth merger; Akorn appoints Raj Rai interim CEO; more...</description>

    <dc:date>2009-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/602720null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/GAO-Recommends-That-FDA-Ensure-Data-Security-withi/ArticleStandard/Article/detail/602699?contextCategoryId=40945&amp;ref=25">

    <title>GAO Recommends That FDA Ensure Data Security within the Sentinel System</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/GAO-Recommends-That-FDA-Ensure-Data-Security-withi/ArticleStandard/Article/detail/602699?contextCategoryId=40945&amp;ref=25</link>

    <description>The US Government Accountability Office recommended that the US Food and Drug Administration draft a
    plan, including milestones, for developing its Sentinel system and ensuring the privacy and security of patients'
    healthcare data.</description>

    <dc:date>2009-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/602699null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-and-Merck-Col/ArticleStandard/Article/detail/601645?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: AstraZeneca and Merck Collaborate on Cancer Drug; Catalent Appoints Senior VP;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-and-Merck-Col/ArticleStandard/Article/detail/601645?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, WACKER expands Iowa facility; EMEA releases a Q&amp;amp;amp;A document for PIPs; Metrics
    consolidates quality operations; more...</description>

    <dc:date>2009-06-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601645null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Truth-and-Transparency/ArticleStandard/Article/detail/600808?contextCategoryId=40945&amp;ref=25">

    <title>Truth and Transparency</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Truth-and-Transparency/ArticleStandard/Article/detail/600808?contextCategoryId=40945&amp;ref=25</link>

    <description>Misleading the public about their investments&amp;amp;mdash;be it money or medicine&amp;amp;mdash;is
    unacceptable.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600808null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Drug-Serialization-and-Supply-Chain-Security/ArticleStandard/Article/detail/601169?contextCategoryId=40945&amp;ref=25">

    <title>Drug Serialization and Supply-Chain Security</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Drug-Serialization-and-Supply-Chain-Security/ArticleStandard/Article/detail/601169?contextCategoryId=40945&amp;ref=25</link>

    <description>As regulators work to curb counterfeiting, industry finds benefits to gaining granular data about the
    supply chain. This article contains bonus online-exclusive material.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601169/Bonus_main.gif</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601169/rotate_counterfeiting_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Quality-in-Quality-Out/ArticleStandard/Article/detail/601167?contextCategoryId=40945&amp;ref=25">

    <title>Quality in, Quality Out</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Quality-in-Quality-Out/ArticleStandard/Article/detail/601167?contextCategoryId=40945&amp;ref=25</link>

    <description>A book guides readers through the regulatory requirements for computerized quality
    systems.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601167/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601167null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Beneath-the-Surface/ArticleStandard/Article/detail/600812?contextCategoryId=40945&amp;ref=25">

    <title>Beneath the Surface</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Beneath-the-Surface/ArticleStandard/Article/detail/600812?contextCategoryId=40945&amp;ref=25</link>

    <description>It can take a lot of work to make sure nothing happens.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600812null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Master-data-management-solutions/ArticleStandard/Article/detail/598921?contextCategoryId=40945&amp;ref=25">

    <title>Master data management solutions</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Master-data-management-solutions/ArticleStandard/Article/detail/598921?contextCategoryId=40945&amp;ref=25</link>

    <description>Cognizant talks about the importance of master data management and its newly launched
    solution.</description>

    <dc:date>2009-06-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/212009/598921null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-Forms-Licensing-Ag/ArticleStandard/Article/detail/600299?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: Pfizer Forms Licensing Agreements; Malvinder Mohan Singh Steps Down at Ranbaxy,
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-Forms-Licensing-Ag/ArticleStandard/Article/detail/600299?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Johnson &amp;amp;amp; Johnson acquires Cougar Biotechnology; NIH launches program for rare and
    neglected diseases; PPD restructures leadership positions; more...</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600299null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Teva-and-Lonza-Joint-Vent/ArticleStandard/Article/detail/599148?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: Teva and Lonza Joint Venture Approved; Novartis CFO to Retire; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Teva-and-Lonza-Joint-Vent/ArticleStandard/Article/detail/599148?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Oxford BioTherapeutics forms drug development pact with GSK; Avila Therapeutics names CEO;
    more...</description>

    <dc:date>2009-05-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/599148null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Teaching-a-New-Robot-Old-Tricks/ArticleStandard/Article/detail/598567?contextCategoryId=40945&amp;ref=25">

    <title>Teaching a New Robot Old Tricks</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Teaching-a-New-Robot-Old-Tricks/ArticleStandard/Article/detail/598567?contextCategoryId=40945&amp;ref=25</link>

    <description>Automation has been part of pharmaceutical processing for some time, but robotics have not yet found
    wide acceptance among drugmakers.</description>

    <dc:date>2009-05-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/598567null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/FDA-Issues-First-Sentinel-Initiative-Project-Repor/ArticleStandard/Article/detail/597996?contextCategoryId=40945&amp;ref=25">

    <title>FDA Issues First Sentinel Initiative Project Report: Statistical Methods</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/FDA-Issues-First-Sentinel-Initiative-Project-Repor/ArticleStandard/Article/detail/597996?contextCategoryId=40945&amp;ref=25</link>

    <description>The first project report on FDA's Sentinel website, discusses the evaluation of existing methods for
    safety signal identification.</description>

    <dc:date>2009-05-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/202009/597996null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-Forms-Pact-with-Aspen/ArticleStandard/Article/detail/598063?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: GSK Forms Pact with Aspen Pharmacare; Sigma-Aldrich Chairman to Retire;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-Forms-Pact-with-Aspen/ArticleStandard/Article/detail/598063?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Takeda to consolidate operations in Ireland; FDA to redesign website; Archemix names president
    and CEO; more...</description>

    <dc:date>2009-05-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/202009/598063null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Jubilant-Biosys-Forms-Pac/ArticleStandard/Article/detail/597076?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: Jubilant Biosys Forms Pact with AstraZeneca; Pfizer Appoints Chief Medical
    Officer; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Jubilant-Biosys-Forms-Pac/ArticleStandard/Article/detail/597076?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Oxford BioMedica forms collaboration with sanofi-aventis; FDA requires labeling changes for
    botulinum toxin producs; C. Richter King joins IAVI; more...</description>

    <dc:date>2009-05-07T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/192009/597076null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Shop-Floor-and-Top-Floor-Unite/ArticleStandard/Article/detail/596049?contextCategoryId=40945&amp;ref=25">

    <title>Shop Floor and Top Floor, Unite!</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Shop-Floor-and-Top-Floor-Unite/ArticleStandard/Article/detail/596049?contextCategoryId=40945&amp;ref=25</link>

    <description>Technology can solve enterprise-level problems.</description>

    <dc:date>2009-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/182009/596049null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/596046?contextCategoryId=40945&amp;ref=25">

    <title>In the Spotlight</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/596046?contextCategoryId=40945&amp;ref=25</link>

    <description>Editors' Picks of Pharmaceutical Science &amp;amp;amp; Technology Innovations</description>

    <dc:date>2009-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/182009/596046null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Biotechnology-in-2009/ArticleStandard/Article/detail/596053?contextCategoryId=40945&amp;ref=25">

    <title>Biotechnology in 2009</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Biotechnology-in-2009/ArticleStandard/Article/detail/596053?contextCategoryId=40945&amp;ref=25</link>

    <description>The president of BIO proposes the ingredients needed for industry growth.</description>

    <dc:date>2009-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/182009/596053null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Greg-Cruikshank-151-scientists-at-the-forefront-of/ArticleStandard/Article/detail/593903?contextCategoryId=40945&amp;ref=25">

    <title>Greg Cruikshank &amp;amp;#151; scientists at the forefront of social networking?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Greg-Cruikshank-151-scientists-at-the-forefront-of/ArticleStandard/Article/detail/593903?contextCategoryId=40945&amp;ref=25</link>

    <description>Pharmaceutical Technology Europe interviews Greg Cruikshank, CEO at LabRoots about the official launch
    of a social networking site for the scientific community.</description>

    <dc:date>2009-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/162009/593903null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Information+Technology/Elevating-laboratory-informatics-to-assist-decisio/ArticleStandard/Article/detail/595063?contextCategoryId=40945&amp;ref=25">

    <title>Elevating laboratory informatics to assist decision-making</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Information+Technology/Elevating-laboratory-informatics-to-assist-decisio/ArticleStandard/Article/detail/595063?contextCategoryId=40945&amp;ref=25</link>

    <description>With pressure to cut costs, shorten the pipeline life cycle and maximize return on investment,
    pharmaceutical manufacturers need tools that help them improve enterprise-wide communications, reach critical
    decisions faster and produce timely, accurate reports on how compounds are progressing.</description>

    <dc:date>2009-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/172009/595063/Shah_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CIGNA-and-Merck-Agree-on-/ArticleStandard/Article/detail/595723?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: CIGNA and Merck Agree on Drug Pricing Plan; Kathleen Sebelius Confirmed as head of
    HHS; More</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CIGNA-and-Merck-Agree-on-/ArticleStandard/Article/detail/595723?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Roche's Avastin trial does not meet endpoint; Innate Pharma names regulatory VP;
    more...</description>

    <dc:date>2009-04-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/182009/595723null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Company-and-People-Notes-GSK-Acquires-Stiefel-Labo/ArticleStandard/Article/detail/594648?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: GSK Acquires Stiefel Laboratories; Roche Announces Changes at Genentech;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Company-and-People-Notes-GSK-Acquires-Stiefel-Labo/ArticleStandard/Article/detail/594648?contextCategoryId=40945&amp;ref=25</link>

    <description>Also: Sanofi-aventis acquires BiPar Sciences; FDA issues Warning Letter to Chinese heparin
    manufacturer; Halo Pharmaceutical appoints chief scientific officer; more...</description>

    <dc:date>2009-04-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/172009/594648null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-DSM-and-Shire-Form-Pact-P/ArticleStandard/Article/detail/593691?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: DSM and Shire Form Pact; Pfizer Names Oncology Unit Exec; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-DSM-and-Shire-Form-Pact-P/ArticleStandard/Article/detail/593691?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Sanofi-aventis acquires Medley and Laboratorios Kendrick; Eli Lilly's Cook to retire from board;
    more...</description>

    <dc:date>2009-04-16T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/162009/593691null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Latest+News/Social-networking-for-scientists/ArticleStandard/Article/detail/591058?contextCategoryId=40945&amp;ref=25">

    <title>Social networking for scientists</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Latest+News/Social-networking-for-scientists/ArticleStandard/Article/detail/591058?contextCategoryId=40945&amp;ref=25</link>

    <description>A new social networking site called LabRoots has been officially launched to help scientists build
    relationships with other scientists and share their expertise.</description>

    <dc:date>2009-04-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/142009/591058null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-BMS-and-Otsuka-Extend-Abi/ArticleStandard/Article/detail/592425?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: BMS and Otsuka Extend Abilify Agreement; Takeda Reorganizes Corporate Structure;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-BMS-and-Otsuka-Extend-Abi/ArticleStandard/Article/detail/592425?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Genzyme and Bayer HealthCare form agreement; FDA releases draft guidances; TransMolecular
    appointed Robert Radie president and CEO</description>

    <dc:date>2009-04-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/152009/592425null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/591371?contextCategoryId=40945&amp;ref=25">

    <title>In the Spotlight</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/591371?contextCategoryId=40945&amp;ref=25</link>

    <description>Editors' Picks of Pharmaceutical Science &amp;amp;amp; Technology Innovations</description>

    <dc:date>2009-04-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/142009/591371null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Parallel-Tracks/ArticleStandard/Article/detail/590455?contextCategoryId=40945&amp;ref=25">

    <title>Parallel Tracks</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Parallel-Tracks/ArticleStandard/Article/detail/590455?contextCategoryId=40945&amp;ref=25</link>

    <description>Obama's cost-containment and science-innovation initiatives need to overlap.</description>

    <dc:date>2009-04-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/142009/590455null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Viewpoint/Automation-Vendor-or-Partner/ArticleStandard/Article/detail/590466?contextCategoryId=40945&amp;ref=25">

    <title>Automation Vendor or Partner?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Viewpoint/Automation-Vendor-or-Partner/ArticleStandard/Article/detail/590466?contextCategoryId=40945&amp;ref=25</link>

    <description>The role of automation suppliers is transforming to meet the pharma industry's demand for
    change.</description>

    <dc:date>2009-04-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/142009/590466null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/PharmTech+Talk/Moving-Toward-a-Drug-Development-Boon-or-Bust/ArticleStandard/Article/detail/590456?contextCategoryId=40945&amp;ref=25">

    <title>Moving Toward a Drug Development Boon or Bust?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/PharmTech+Talk/Moving-Toward-a-Drug-Development-Boon-or-Bust/ArticleStandard/Article/detail/590456?contextCategoryId=40945&amp;ref=25</link>

    <description>The financial and economic downturn is likey to have long-term implications for
    outsourcing.</description>

    <dc:date>2009-04-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/142009/590456null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-EMD-Serono-to-Open-Cambri/ArticleStandard/Article/detail/590969?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: EMD Serono to Open Cambridge, MA, site; Akorn Appoints Interim CEO;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-EMD-Serono-to-Open-Cambri/ArticleStandard/Article/detail/590969?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, SOCMA changes name; two FDA approvals; Biogen Idec names chief operating officer;
    more...</description>

    <dc:date>2009-04-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/142009/590969null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Daiichi-Sankyo-Sues-13-Ge/ArticleStandard/Article/detail/589404?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: Daiichi Sankyo Sues 13 Generic Drugmakers; Ischemix Appoints CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Daiichi-Sankyo-Sues-13-Ge/ArticleStandard/Article/detail/589404?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Hospira to reduce workforce; WuXi AppTech makes senior appointments; more...</description>

    <dc:date>2009-03-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/132009/589404null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Gilead-Sciences-to-Acquir/ArticleStandard/Article/detail/587538?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: Gilead Sciences to Acquire CV Therapeutics; DOR Biopharma Appoints Chief Medical
    Officer; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Gilead-Sciences-to-Acquir/ArticleStandard/Article/detail/587538?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Genzyme receives warning letter; Mesa Laboratories appoints John J. Sullivan CEO and a member of
    the board of directors; more...</description>

    <dc:date>2009-03-19T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/122009/587538null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-MannKind-to-Purchase-Pfiz/ArticleStandard/Article/detail/586726?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: MannKind to Purchase Pfizer Facility; Catalent Appoints President and CEO;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-MannKind-to-Purchase-Pfiz/ArticleStandard/Article/detail/586726?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Penn Pharma to expand; stem cell research funding ban lifted; Bristol-Myers Squibb made senior
    appointments; more...</description>

    <dc:date>2009-03-12T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/112009/586726null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Elan-Announces-Restructur/ArticleStandard/Article/detail/584824?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: Elan Announces Restructuring; Von Eschenbach Joins Greenleaf Health;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Elan-Announces-Restructur/ArticleStandard/Article/detail/584824?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Schering-Plough's vaccine unit, Nobilon, formed an agreement with the World Health Organization;
    Ore Pharmaceuticals named president and CEO; more...</description>

    <dc:date>2009-03-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/102009/584824null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/API-Outsourcing-is-Mixed/ArticleStandard/Article/detail/584962?contextCategoryId=40945&amp;ref=25">

    <title>API Outsourcing is Mixed</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/API-Outsourcing-is-Mixed/ArticleStandard/Article/detail/584962?contextCategoryId=40945&amp;ref=25</link>

    <description>Contract manufacturers of APIs and intermediates report gains, but express caution.</description>

    <dc:date>2009-03-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/102009/584962null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Critical-Challenges-Require-Core-Values/ArticleStandard/Article/detail/584960?contextCategoryId=40945&amp;ref=25">

    <title>Critical Challenges Require Core Values</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Critical-Challenges-Require-Core-Values/ArticleStandard/Article/detail/584960?contextCategoryId=40945&amp;ref=25</link>

    <description>Industry has changed, but its basic tenets have not. INTERPHEX's RJ Palermo discusses a 7-step process
    to keep pharma moving forward.</description>

    <dc:date>2009-03-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/102009/584960null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/584965?contextCategoryId=40945&amp;ref=25">

    <title>In the Spotlight</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/584965?contextCategoryId=40945&amp;ref=25</link>

    <description>Editors' Picks of Pharmaceutical Science &amp;amp;amp; Technology Innovations</description>

    <dc:date>2009-03-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/102009/584965null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Latest+News/Drug-discovery-the-cheap-way/ArticleStandard/Article/detail/582718?contextCategoryId=40945&amp;ref=25">

    <title>Drug discovery the cheap way</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Latest+News/Drug-discovery-the-cheap-way/ArticleStandard/Article/detail/582718?contextCategoryId=40945&amp;ref=25</link>

    <description>Could the traditional drug discovery method of beginning with a natural chemical and systematically
    modifying it chemical structure be replaced by a new, cheap and efficient method?</description>

    <dc:date>2009-02-26T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/082009/582718null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Genentech-Tells-Sharehold/ArticleStandard/Article/detail/583427?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: Genentech Tells Shareholders to Reject Roche's Tender Offer; Cryoport Appoints
    President and CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Genentech-Tells-Sharehold/ArticleStandard/Article/detail/583427?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, GPC Biotech AG and Agennix to merge; BASi appoints COO of scientific services;
    more...</description>

    <dc:date>2009-02-26T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/092009/583427null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-KV-Pharmaceutical-Restruc/ArticleStandard/Article/detail/582512?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: KV Pharmaceutical Restructures; Otsuka America Appoints Mark Altmeyer President
    and CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-KV-Pharmaceutical-Restruc/ArticleStandard/Article/detail/582512?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, Sandoz received approval for its third biosimilar from the EU, WuXi PharmaTech's CFO Benson
    Tsang to leave at month's end; more...</description>

    <dc:date>2009-02-19T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/082009/582512null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Releases-Five-Year-Drug-Safety-Plan/ArticleStandard/Article/detail/582342?contextCategoryId=40945&amp;ref=25">

    <title>FDA Releases Five-Year Drug Safety Plan</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Releases-Five-Year-Drug-Safety-Plan/ArticleStandard/Article/detail/582342?contextCategoryId=40945&amp;ref=25</link>

    <description>The US Food and Drug Administration posted the Prescription Drug User Fee Act (PDUFA) IV Drug Safety
    Five-Year Plan on its website.</description>

    <dc:date>2009-02-19T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/082009/582342null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Bridging-the-DevelopmentndashManufacturing-Gap-to-/ArticleStandard/Article/detail/581287?contextCategoryId=40945&amp;ref=25">

    <title>Bridging the Development&amp;amp;ndash;Manufacturing Gap to Achieve QbD and PAT</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Bridging-the-DevelopmentndashManufacturing-Gap-to-/ArticleStandard/Article/detail/581287?contextCategoryId=40945&amp;ref=25</link>

    <description>To implement QbD and reduce business risks, teams should begin QbD collaboration early during process
    development.</description>

    <dc:date>2009-02-18T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/072009/581287null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Congress-Introduces-FDA-Globalization-Act-of-2009/ArticleStandard/Article/detail/580861?contextCategoryId=40945&amp;ref=25">

    <title>Congress Introduces FDA Globalization Act of 2009</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Congress-Introduces-FDA-Globalization-Act-of-2009/ArticleStandard/Article/detail/580861?contextCategoryId=40945&amp;ref=25</link>

    <description>Congressman John D. Dingell (D-MI) introduced HR 759, known as the Food and Drug Globalization Act of
    2009, which would amend the Food, Drug, and Cosmetic Act to address food, drug, and device safety, including
    registration of producers of drugs and applicable fees, documentation for admissibility of drug imports, country of
    origin labeling, and the inspection of producers of drugs and active pharmaceutical ingredients
    (API).</description>

    <dc:date>2009-02-12T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/072009/580861null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-King-Announces-Restructur/ArticleStandard/Article/detail/580965?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: King Announces Restructuring; SCOLR Pharma Appoints President and CEO;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-King-Announces-Restructur/ArticleStandard/Article/detail/580965?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, PPD to acquire AbC.R.O.; Bilcare Global Clinical Supplies named Tony Moult general manager of
    Bilcare GCS Europe; more...</description>

    <dc:date>2009-02-12T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/072009/580965null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-Announces-Mor/ArticleStandard/Article/detail/579768?contextCategoryId=40945&amp;ref=25">

    <title>Company and People Notes: AstraZeneca Announces More Job Cuts; Deirdre Connelly Leaves Eli Lilly for GSK;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-Announces-Mor/ArticleStandard/Article/detail/579768?contextCategoryId=40945&amp;ref=25</link>

    <description>Also, recalls for two KV Pharmaceutical subsidiaries; Human Genome Sciences delivers anthrax drug to
    US Strategic National Stockpile; Akorn president and CEO leaves the company; more...</description>

    <dc:date>2009-02-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062009/579768null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Drug-Prices-Remain-on-the-Cutting-Board/ArticleStandard/Article/detail/580028?contextCategoryId=40945&amp;ref=25">

    <title>Drug Prices Remain on the Cutting Board</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Drug-Prices-Remain-on-the-Cutting-Board/ArticleStandard/Article/detail/580028?contextCategoryId=40945&amp;ref=25</link>

    <description>Efforts to cut healthcare outlays will focus on drug costs, despite a drop in prescription
    sales.</description>

    <dc:date>2009-02-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062009/580028null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Whither-FDA/ArticleStandard/Article/detail/580023?contextCategoryId=40945&amp;ref=25">

    <title>Whither FDA?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Whither-FDA/ArticleStandard/Article/detail/580023?contextCategoryId=40945&amp;ref=25</link>

    <description>FDA's role should not be overlooked as it has been in years past.</description>

    <dc:date>2009-02-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062009/580023null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Pharma-Forecast/ArticleStandard/Article/detail/580024?contextCategoryId=40945&amp;ref=25">

    <title>Pharma Forecast</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Pharma-Forecast/ArticleStandard/Article/detail/580024?contextCategoryId=40945&amp;ref=25</link>

    <description>A recent reader poll focused on predictions for the industry's future.</description>

    <dc:date>2009-02-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062009/580024null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Ask-the-Expert-bridging-the-gaps/ArticleStandard/Article/detail/576863?contextCategoryId=40945&amp;ref=25">

    <title>Ask the Expert: bridging the gaps</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Ask-the-Expert-bridging-the-gaps/ArticleStandard/Article/detail/576863?contextCategoryId=40945&amp;ref=25</link>

    <description>ask the expert</description>

    <dc:date>2009-02-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/042009/576863null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Information+Technology/Efficient-logistic-operations/ArticleStandard/Article/detail/577856?contextCategoryId=40945&amp;ref=25">

    <title>Efficient logistic operations</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Information+Technology/Efficient-logistic-operations/ArticleStandard/Article/detail/577856?contextCategoryId=40945&amp;ref=25</link>

    <description>Ask the Expert looks at logistic problems.</description>

    <dc:date>2009-02-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/052009/577856null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>
</rdf:RDF>


